Correction Report: Stock Option Exercise Price Lowered and Grant Size Reduced
-
Grant recipients reduced from 5 to 4; shares granted reduced from 30,500 to 15,500
-
Exercise price lowered from 33,780 won to 9,760 won (adjusted per contract due to capital increases)
-
Total outstanding options after this grant increased from 1,941,396 to 4,092,568 shares
-
Fair value per option changed from 36,062 won to 35,733 won (minor adjustment)
KOSDAQ Filing Information
-
Filing: [Correction of Description] Report on Grant of Stock Options
-
Company: Genome & (314130)
-
Submission: Genome & Company
-
Receipt: 05-14-2026